Recall
FDAHealthMarch 27, 2026

Appco Pharma LLC — Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377

⚠️ cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
March 27, 2026

U.S.A. Nationwide

What's affected?

Product
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.
Lot code
2404153UC

Additional details

Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 58,896 bottles- 100's count.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.